|Articles|July 15, 2002

BioPharm International

  • BioPharm International-07-01-2002
  • Volume 15
  • Issue 7

Inside Washington: One Hundred Years of Biotech Regulation

Author(s)Jill Wechsler

by Jill Wechsler, CBER is heralding its rich regulatory history while preparing to tackle new scientific and administrative challenges.
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

over 23 years ago

Facilitating Client Audits: The Contract Laboratory Perspective

over 23 years ago

Outsourcing Outlook: Optimizing Cross-Organizational Team Performance and Management

over 23 years ago

Analytical Advances: When an Industry Requires Multiterabyte Data Protection

over 23 years ago

Validation of Large-Scale Chromatographic Processes, Part 2: Results from the Case Study of Neuleze Capture on Macroprep High-S

over 23 years ago

Knowledge Management: The Four Pillars of Success

over 23 years ago

Guest Editorial: Supreme Court Rules on Festo

over 23 years ago

Optimizing Recombinant Microbial Fermentation Processes: An Integrated Approach

over 23 years ago

Virus Inactivation in the 1990's ? and into the 21st Century. Part 1: Skin, Bone, and Cells

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us